Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
Clinical trial NCT02734290 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02734290
- Sponsor
- Providence Health & Services
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2019-08-21
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.